290 related articles for article (PubMed ID: 37202575)
21. Synergistic tumor microenvironment targeting and blood-brain barrier penetration via a pH-responsive dual-ligand strategy for enhanced breast cancer and brain metastasis therapy.
Li M; Shi K; Tang X; Wei J; Cun X; Long Y; Zhang Z; He Q
Nanomedicine; 2018 Aug; 14(6):1833-1843. PubMed ID: 29800759
[TBL] [Abstract][Full Text] [Related]
22. Nanoparticles Containing a Combination of a Drug and an Antibody for the Treatment of Breast Cancer Brain Metastases.
Wyatt EA; Davis ME
Mol Pharm; 2020 Feb; 17(2):717-721. PubMed ID: 31916770
[TBL] [Abstract][Full Text] [Related]
23. Systemic Therapy for Lung Cancer Brain Metastases.
Pellerino A; Bruno F; Rudà R; Soffietti R
Curr Treat Options Oncol; 2021 Oct; 22(12):110. PubMed ID: 34693454
[TBL] [Abstract][Full Text] [Related]
24. A tissue-engineered model of the blood-tumor barrier during metastatic breast cancer.
Linville RM; Maressa J; Guo Z; Chung TD; Farrell A; Jha R; Searson PC
Fluids Barriers CNS; 2023 Nov; 20(1):80. PubMed ID: 37924145
[TBL] [Abstract][Full Text] [Related]
25. Harnessing nanomedicine for enhanced immunotherapy for breast cancer brain metastases.
Carney CP; Pandey N; Kapur A; Woodworth GF; Winkles JA; Kim AJ
Drug Deliv Transl Res; 2021 Dec; 11(6):2344-2370. PubMed ID: 34716900
[TBL] [Abstract][Full Text] [Related]
26. Heterogeneous blood-tumor barrier permeability determines drug efficacy in experimental brain metastases of breast cancer.
Lockman PR; Mittapalli RK; Taskar KS; Rudraraju V; Gril B; Bohn KA; Adkins CE; Roberts A; Thorsheim HR; Gaasch JA; Huang S; Palmieri D; Steeg PS; Smith QR
Clin Cancer Res; 2010 Dec; 16(23):5664-78. PubMed ID: 20829328
[TBL] [Abstract][Full Text] [Related]
27. Molecular landscape and emerging therapeutic strategies in breast cancer brain metastasis.
Xiong S; Tan X; Wu X; Wan A; Zhang G; Wang C; Liang Y; Zhang Y
Ther Adv Med Oncol; 2023; 15():17588359231165976. PubMed ID: 37034479
[TBL] [Abstract][Full Text] [Related]
28. Serum-derived factors of breast cancer patients with brain metastases alter permeability of a human blood-brain barrier model.
Curtaz CJ; Schmitt C; Herbert SL; Feldheim J; Schlegel N; Gosselet F; Hagemann C; Roewer N; Meybohm P; Wöckel A; Burek M
Fluids Barriers CNS; 2020 Apr; 17(1):31. PubMed ID: 32321535
[TBL] [Abstract][Full Text] [Related]
29. Alterations in Pericyte Subpopulations Are Associated with Elevated Blood-Tumor Barrier Permeability in Experimental Brain Metastasis of Breast Cancer.
Lyle LT; Lockman PR; Adkins CE; Mohammad AS; Sechrest E; Hua E; Palmieri D; Liewehr DJ; Steinberg SM; Kloc W; Izycka-Swieszewska E; Duchnowska R; Nayyar N; Brastianos PK; Steeg PS; Gril B
Clin Cancer Res; 2016 Nov; 22(21):5287-5299. PubMed ID: 27245829
[TBL] [Abstract][Full Text] [Related]
30. Cell-cell communication characteristics in breast cancer metastasis.
Xu J; Gao F; Liu W; Guan X
Cell Commun Signal; 2024 Jan; 22(1):55. PubMed ID: 38243240
[TBL] [Abstract][Full Text] [Related]
31. Are capecitabine and the active metabolite 5-Fu CNS penetrable to treat breast cancer brain metastasis?
Zhang J; Zhang L; Yan Y; Li S; Xie L; Zhong W; Lv J; Zhang X; Bai Y; Cheng Z
Drug Metab Dispos; 2015 Mar; 43(3):411-7. PubMed ID: 25547867
[TBL] [Abstract][Full Text] [Related]
32. [Brain metastases epidemiology and biology].
Tabouret E; Bauchet L; Carpentier AF
Bull Cancer; 2013 Jan; 100(1):57-62. PubMed ID: 23303801
[TBL] [Abstract][Full Text] [Related]
33. Breast cancer brain metastasis: insight into molecular mechanisms and therapeutic strategies.
Wang Y; Ye F; Liang Y; Yang Q
Br J Cancer; 2021 Oct; 125(8):1056-1067. PubMed ID: 34226684
[TBL] [Abstract][Full Text] [Related]
34. ADAM22/LGI1 complex as a new actionable target for breast cancer brain metastasis.
Charmsaz S; Doherty B; Cocchiglia S; Varešlija D; Marino A; Cosgrove N; Marques R; Priedigkeit N; Purcell S; Bane F; Bolger J; Byrne C; O'Halloran PJ; Brett F; Sheehan K; Brennan K; Hopkins AM; Keelan S; Jagust P; Madden S; Martinelli C; Battaglini M; Oesterreich S; Lee AV; Ciofani G; Hill ADK; Young LS
BMC Med; 2020 Nov; 18(1):349. PubMed ID: 33208158
[TBL] [Abstract][Full Text] [Related]
35. Nanomaterials for brain metastasis.
Zhao Z; Chen Y; Sun T; Jiang C
J Control Release; 2024 Jan; 365():833-847. PubMed ID: 38065414
[TBL] [Abstract][Full Text] [Related]
36. Growth inhibition in a brain metastasis model by antibody delivery using focused ultrasound-mediated blood-brain barrier disruption.
Kobus T; Zervantonakis IK; Zhang Y; McDannold NJ
J Control Release; 2016 Sep; 238():281-288. PubMed ID: 27496633
[TBL] [Abstract][Full Text] [Related]
37. Gelatin-methacryloyl hydrogel based
Augustine R; Zahid AA; Mraiche F; Alam K; Al Moustafa AE; Hasan A
Pharm Dev Technol; 2021 Apr; 26(4):490-500. PubMed ID: 33416013
[TBL] [Abstract][Full Text] [Related]
38. The role of astrocytes in brain metastasis at the interface of circulating tumour cells and the blood brain barrier.
Burn L; Gutowski N; Whatmore J; Giamas G; Pranjol MZI
Front Biosci (Landmark Ed); 2021 Sep; 26(9):590-601. PubMed ID: 34590469
[TBL] [Abstract][Full Text] [Related]
39. Impact of Docetaxel on blood-brain barrier function and formation of breast cancer brain metastases.
Bernatz S; Ilina EI; Devraj K; Harter PN; Mueller K; Kleber S; Braun Y; Penski C; Renner C; Halder R; Jennewein L; Solbach C; Thorsen F; Pestalozzi BC; Mischo A; Mittelbronn M
J Exp Clin Cancer Res; 2019 Oct; 38(1):434. PubMed ID: 31665089
[TBL] [Abstract][Full Text] [Related]
40. Facile synthesis of lactoferrin conjugated ultra small large pore silica nanoparticles for the treatment of glioblastoma.
Janjua TI; Ahmed-Cox A; Meka AK; Mansfeld FM; Forgham H; Ignacio RMC; Cao Y; McCarroll JA; Mazzieri R; Kavallaris M; Popat A
Nanoscale; 2021 Oct; 13(40):16909-16922. PubMed ID: 34533167
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
